This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 1,853 
Years Active: 2024
Title: Liliane Massade: Innovator in Antisense RNA Technology
Introduction
Liliane Massade is a prominent inventor based in Cachan, France. She has made significant contributions to the field of molecular biology, particularly in the development of antisense RNA technology. Her work focuses on innovative treatments for genetic disorders, showcasing her dedication to advancing medical science.
Latest Patents
Liliane Massade holds a patent for "Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease." This invention relates to antisense RNAs that target PMP22 and can inhibit the expression of this gene in cells by 40% to 60%. The patent emphasizes the use of siRNA, preferably delivered in the form of nanoparticles, to effectively treat Charcot-Marie-Tooth 1A disease.
Career Highlights
Throughout her career, Liliane has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Charbel Massaad and Susan Boutary. Their collaborative efforts have furthered the understanding and application of antisense RNA technology in medical treatments.
Conclusion
Liliane Massade's innovative work in antisense RNA technology represents a significant advancement in the treatment of genetic disorders. Her contributions continue to inspire future research and development in the field of molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile